Geospatial environmental complexity, spatial brain volume, and spatial behavior across the Alzheimer's disease spectrum is a dataset published in Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2024). On theSindex it has a DataRank of 0.518, placing it in the top 37.3% of the data-sharing corpus. It has been cited 11 times, with 10 citing works in its 1-hop citation network. Its calibrated FAIR score is 6/100.
Ranks in the top 37% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Full FAIR picture · advisory
The headline score is computed from the scored criteria — the fact-shaped checks (a repository, an accession, a licence) that two independent models agree on. The advisory criteria below are real FAIR guidance but rest on judgment calls that models read differently, so they inform without moving the number.
No persistent identifier is assigned to the study's own data; the NACC URL is not the study's own identifier. [majority verdict 'no' (3/5 passes agreed)]
RDA-F1-01D — FAIR Data Maturity Model: 'Data is identified by a persistent identifier' (priorit · RDA-F1-02D — FAIR Data Maturity Model: 'Data is identified by a globally unique identifier' · FsF-F1-02D — F-UJI/FAIRsFAIR: 'Data is assigned a persistent identifier'
No repository is named as the holder of the study's own data; the NACC is a source of input data, not the study's own deposit. [majority verdict 'no' (2/5 passes agreed)]
RDA-F4-01M — FAIR Data Maturity Model: metadata is offered so it can be harvested and indexed ( · NIH DMS Policy Element 4 (NOT-OD-21-014) — name the repository where data will be archived · NSTC Desirable Characteristics of Data Repositories (2022) — 'Long-Term Sustainability', 'Reten
No identifier for the study's own dataset appears in either the body text or the reference list. [majority verdict 'no' (4/5 passes agreed)]
FORCE11 Joint Declaration of Data Citation Principles (2014) — data should be cited as a first- · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes · FsF-F3-01M — F-UJI: 'Metadata includes the identifier of the data it describes'
Advisory · not in the published score
“The data that support the findings of this study are available from the National Alzheimer's Coordinating Center ( https://naccdata.org ) but restrictions apply to the availability of these data, which were used under formal approval for the current study, and so are not publicly available from the authors.”
The statement points to a repository (NACC) but without a specific accession or DOI for the dataset, and includes restrictions, so it is not a repository record. [majority verdict 'partial' (3/5 passes agreed)]
Colavizza, Hrynaszkiewicz, Staden, Whitaker & McGillivray (2020), 'The citation advantage of li · Springer Nature research data policy — Data Availability Statements: standard statement templat · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes
The paper does not have an itemised inventory or section describing the dataset's files, variables, or samples. [majority verdict 'no' (4/5 passes agreed)]
RDA-F2-01M — 'Rich metadata is provided to allow discovery' (priority Essential) · FsF-F2-01M — F-UJI: 'Metadata includes descriptive core elements to support data findability' · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data'
“The data that support the findings of this study are available from the National Alzheimer's Coordinating Center ( https://naccdata.org ) but restrictions apply to the availability of these data, which were used under formal approval for the current study, and so are not publicly available from the authors.”
The DAS states restrictions and a formal approval requirement, which is a precondition, but the process is not specified; thus it is not a followable route. [majority verdict 'no' (3/5 passes agreed)]
RDA-A1.1-01D — 'Data is accessible through a free access protocol' · FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · NSTC Desirable Characteristics of Data Repositories (2022) — 'Free and Easy Access'
Advisory · not in the published score
“The data that support the findings of this study are available from the National Alzheimer's Coordinating Center (https://naccdata.org) but restrictions apply to the availability of these data, which were used under formal approval for the current study, and so are not publicly available from the authors.”— not found in the paper; verdict downgraded
The paper states that restrictions apply and the data are not publicly available, but does not use a standard access-level label such as 'restricted access'; it describes the access condition without labeling it. [downgraded to 'no' — no verifiable quote from the paper] [majority verdict 'no' (2/5 passes agreed)]
FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · RDA-A1-01M — metadata contains information to enable the user to get access to the data · COAR Controlled Vocabularies — Access Rights v1.0 (open / embargoed / restricted / metadata-onl
“The data that support the findings of this study are available from the National Alzheimer's Coordinating Center (https://naccdata.org) but restrictions apply to the availability of these data, which were used under formal approval for the current study, and so are not publicly available from the authors.”— not found in the paper; verdict downgraded
The paper names the National Alzheimer's Coordinating Center (NACC) as the gatekeeper, which requires a formal approval process, thus an institutional gatekeeper. [downgraded to 'partial' — no verifiable quote from the paper] [majority verdict 'partial' (3/5 passes agreed)]
NIH Genomic Data Sharing Policy (NOT-OD-14-124) — controlled-access via a Data Access Committee · RDA-A1.2-01D — 'Data is accessible through an access protocol that supports authentication and · NIH DMS Policy Element 5 (NOT-OD-21-014) — Access, Distribution, or Reuse Considerations (conse
No statement about how long the data will be retained or available.
NIH DMS Plan Element 4 (NOT-OD-21-014) — Data Preservation, Access, and Associated Timelines · NSTC Desirable Characteristics (2022), Organizational Infrastructure: 'Retention Policy' · RDA-A2-01M — 'Metadata is guaranteed to remain available after data is no longer available'
No file format is mentioned for the released data.
FsF-R1.3-02D — F-UJI: 'Data is available in a file format recommended by the target research co · RDA-R1.3-02D — data is expressed in a machine-understandable community standard · RDA-I1-01D — data uses a knowledge representation expressed in a standardised format
Advisory · not in the published score
No community data or metadata standard is named.
RDA-R1.3-01M — 'Metadata complies with a community standard' (priority Essential) · RDA-R1.3-01D — 'Data complies with a community standard' · RDA-I2-01M — '(Meta)data use vocabularies that follow FAIR principles'
The paper does not provide a persistent identifier for any external resource (e.g., NACC is only a URL, and no DOIs or accessions are given for third-party data). [majority verdict 'no' (3/5 passes agreed)]
RDA-I3-01M — '(meta)data include references to other (meta)data' · RDA-I3-03M — 'metadata includes qualified references to other metadata' · FsF-I3-01M — F-UJI: 'Metadata includes links between the data and its related entities'
No license is attached to the data; the CC BY-NC license applies only to the article.
RDA-R1.1-01M — 'Metadata includes information about the licence under which the data can be reu · RDA-R1.1-02M — 'Metadata refers to a standard reuse licence' · RDA-R1.1-03M — 'Metadata refers to a machine-understandable reuse licence'
“We retrieved the data set that includes patients that were recruited at the Alzheimer's Disease Centers between January 2005 and January 08, 2021.”
A date range is given for the data extraction, which pins the snapshot. [majority verdict 'partial' (3/5 passes agreed)]
DataCite Metadata Schema 4.6 — the 'Version' property · RDA-R1.2-01M — provenance information (which version was used is provenance) · NSTC Desirable Characteristics of Data Repositories (2022) — 'Provenance', 'Retention Policy'
No code availability statement or locator is provided.
NIH DMS Policy Element 2 (NOT-OD-21-014) — 'Related Tools, Software and/or Code' · FAIR4RS Principles v1.0 (Chue Hong et al., 2022; RDA/FORCE11/ReSA) — FAIR Principles for Resear · FORCE11 Software Citation Principles (Smith, Katz & Niemeyer, 2016, PeerJ CS 2:e86)
“National Institutes of Health 10.13039/100000002 R21 AG069267 NIA/NIH U24 AG072122”
The paper lists specific grant numbers (R21 AG069267, U24 AG072122, and many P30/P20 grants).
DataCite Metadata Schema 4.6 — 'FundingReference' property (funderName, funderIdentifier, award · Crossref Funder Registry — canonical funder identifiers for funding metadata · RDA-F2-01M — rich metadata provided to allow discovery (funding is part of the descriptive reco
Advisory · not in the published score
“The T1-weighted volumetric MRI quantification data were provided to the NACC by the iDeA lab at the University of California, Davis (Director: Charles DeCarli, MD; https://idealab.ucdavis.edu ), by following the ADNI four-tissue segmentation protocol, as fully described at https://adni.loni.usc.edu/methods/ . Hippocampal volume was obtained via manual segmentation following the EADC-ADNI harmonized protocol.”
The paper names specific instruments and protocols used to produce the data. [majority verdict 'yes' (3/5 passes agreed)]
RDA-R1.2-01M — 'Metadata includes provenance information according to community- specific standa · FsF-R1.2-01M — F-UJI: 'Metadata includes provenance information about data creation or generati · W3C PROV-O (W3C Recommendation, 2013) — the entity/activity/agent model of provenance
No documentation object (README, codebook, schema) is named as accompanying the data. [majority verdict 'no' (3/5 passes agreed)]
RDA-R1-01M — '(Meta)data are richly described with a plurality of accurate and relevant attribu · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data' · NIH DMS Policy Element 3 (NOT-OD-21-014) — Standards (documentation and metadata to accompany t
Calibrated FAIR score — a parallel quality metric, independent of the DataRank citation score. See the full evaluation →
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0.146
From 7 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 10 citers.
National Institutes of Health
Grant: R21 AG069267
NIA NIH HHS
Grant: P30 AG062421
NIA NIH HHS
Grant: P30 AG066519
NIA NIH HHS
Grant: P30 AG072931
NIA NIH HHS
Grant: P30 AG072975
NIA NIH HHS
Grant: R01 AG079280
NIA NIH HHS
Grant: P20 AG068077
NIA NIH HHS
Grant: P30 AG062715
NIA NIH HHS
Grant: P30 AG066508
NIA NIH HHS
Grant: P30 AG072978
NIA NIH HHS
Grant: P30 AG066507
NIA NIH HHS
Grant: P30 AG066518
NIA NIH HHS
Grant: P30 AG066546
NIA NIH HHS
Grant: P30 AG072973
NIA NIH HHS
Grant: P30 AG062677
NIA NIH HHS
Grant: P30 AG066462
NIA NIH HHS
Grant: P30 AG072959
NIA NIH HHS
Grant: P30 AG062429
NIA NIH HHS
Grant: P30 AG072946
NIA NIH HHS
Grant: P30 AG072977
NIA NIH HHS
Grant: P20 AG068082
NIA NIH HHS
Grant: P30 AG062422
NIA NIH HHS
Grant: P30 AG066506
NIA NIH HHS
Grant: P30 AG072947
NIA NIH HHS
Grant: P30 AG072958
NIA NIH HHS
Grant: P30 AG072972
NIA NIH HHS
Grant: P30 AG072976
NIA NIH HHS
Grant: P30 AG072979
NIA NIH HHS
Grant: P30 AG066444
NIA NIH HHS
Grant: P30 AG066509
NIA NIH HHS
Grant: P30 AG066512
NIA NIH HHS
Grant: P30 AG066514
NIA NIH HHS
Grant: P30 AG066530
NIA NIH HHS
Grant: U24 AG072122
NIA NIH HHS
Grant: P20 AG068024
NIA NIH HHS
Grant: P20 AG068053
NIA NIH HHS
Grant: P30 AG066468
NIA NIH HHS
Grant: P30 AG066511
NIA NIH HHS
Grant: P30 AG066515
National Institutes of Health
Grant: 5P30AG072947-02
Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5P30AG072979-02
Penn Alzheimer's Disease Research Center (ADRC)
National Institutes of Health
Grant: 1P30AG066512-01
Alzheimer's Disease Research Center
National Institutes of Health
Grant: 1P30AG066506-01
1Florida Alzheimer's Disease Research Center
National Institutes of Health
Grant: 3P30AG066530-04S1
Alzheimer Disease Research Center
National Institutes of Health
Grant: 1P30AG066546-01A1
South Texas Alzheimer's Disease Center
National Institutes of Health
Grant: 5P30AG062677-02
Mayo Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5P20AG068024-02
UAB Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5P30AG066508-03
Yale Alzheimer Disease Research Center
National Institutes of Health
Grant: 5P30AG062421-03
Massachusetts Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5P30AG066518-03
Oregon Alzheimer's Disease Research Center
National Institutes of Health
Grant: 3P30AG066514-01S1
Alzheimer's Disease Research Center
National Institutes of Health
Grant: 1P30AG072978-01
Boston University Alzheimer's Disease Research Center
National Institutes of Health
Grant: 3P30AG072946-02S1
Portable and modular UDS Data Collection software to increase collaboration and engagement of Alzheimer’s Disease Research Center research software engineers
National Institutes of Health
Grant: 1R21AG069267-01
The Effects of Cognitive Map Building on the Development of Alzheimer's Disease
National Institutes of Health
Grant: 5P30AG072977-02
NORTHWESTERN Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5U24AG072122-03
National Alzheimer's Coordinating Center
National Institutes of Health
Grant: 5P30AG072975-02
Rush Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5P20AG068082-02
Vanderbilt Alzheimer's Disease Research Center
National Institutes of Health
Grant: 3P30AG066509-03S1
Biological heterogeneity in ADRD
National Institutes of Health
Grant: 5P30AG062422-03
New Approaches to Dementia Heterogeneity
National Institutes of Health
Grant: 5P30AG062715-02
Wisconsin Alzheimer's Disease Research center
National Institutes of Health
Grant: 3P30AG066462-01S1
Alzheimer's Disease Research Center Determinants of health seeking behaviors during COVID-19 in persons with MCI/ADRD and their caregivers
National Institutes of Health
Grant: 1P30AG072972-01
UC Davis Alzheimer's Disease Research Center
National Institutes of Health
Grant: 1P30AG066444-01
Alzheimer's Disease Research Center
National Institutes of Health
Grant: 1P30AG072958-01
Duke/UNC Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5P30AG066515-03
Stanford Alzheimer's Disease Research Center
National Institutes of Health
Grant: 3P30AG066519-01S1
The Alzheimer's Disease Research Center at the University of California, Irvine
National Institutes of Health
Grant: 5P30AG062429-03
UCSD Alzheimer's Disease Research Centers P30
National Institutes of Health
Grant: 3P30AG066468-01S1
Comparison of tau-PET tracers: Progress towards a universal measure
National Institutes of Health
Grant: 3P30AG066511-03S2
Piloting a web-based neuropathology image resource for the ADRC community
National Institutes of Health
Grant: 5P30AG066507-03
Johns Hopkins Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5P30AG072959-02
Cleveland Alzheimers Disease Research Center
National Institutes of Health
Grant: 5P20AG068077-03
New Mexico Alzheimer's Disease Research Center
National Institutes of Health
Grant: 1P30AG072973-01
University of Kansas Alzheimer's Disease Research Center (KU ADRC)
National Institutes of Health
Grant: 5P20AG068053-03
Nevada Exploratory Alzheimer's Disease Research Center (NVEADRC)
National Institutes of Health
Grant: 5P30AG072976-02
Indiana Alzheimer's Disease Research Center
National Institutes of Health
Grant: 1P30AG072931-01
Michigan Alzheimer's Disease Research Center
FWCI
1.32
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals